Sotalol
Sotalol is a 1st-generation, nonselective beta-blocker with additional Class III antiarrhythmic properties.
It blocks:
• β1 receptors • β2 receptors • Cardiac potassium channels (IKr)
Because of its potassium channel blockade, sotalol prolongs the QT interval.
Classification: • 1st Generation (Nonselective) • Also a Class III Antiarrhythmic • No intrinsic sympathomimetic activity (ISA)
→ Beta-Blockers Overview → Dysrhythmias Module
Mechanism of Action
Beta-blocking effects:
• ↓ Heart rate • ↓ AV nodal conduction • ↓ Renin release
Class III antiarrhythmic effects:
• Blocks potassium channels • Prolongs action potential duration • Prolongs QT interval • Increases refractory period
Net Effect:
• Suppresses atrial and ventricular arrhythmias
Unlike most beta-blockers, sotalol significantly prolongs QT.
Indications
Atrial Fibrillation / Atrial Flutter
• Rhythm control (not just rate control)
Ventricular Arrhythmias
• Suppression of ventricular tachycardia
Sotalol is NOT commonly used for hypertension.
Major Risk: Torsades de Pointes
Because sotalol prolongs QT:
• Risk of torsades de pointes • Risk increases with:
- Renal impairment
- Electrolyte abnormalities
- High doses
Initiation often requires ECG monitoring.
QT prolongation is dose-dependent.
Pharmacokinetics
• Hydrophilic • Renally cleared • Minimal CNS penetration
Dose adjustment required in renal impairment.
Adverse Effects
Beta-blocker effects:
• Bradycardia • Hypotension • Fatigue • Bronchospasm
Class III effects:
• QT prolongation • Torsades de pointes
Contraindications
• Baseline prolonged QT • Severe bradycardia • High-grade AV block • Cardiogenic shock • Significant renal impairment • Hypokalemia or hypomagnesemia
Sotalol vs Other Beta-Blockers
Most beta-blockers: • Do NOT prolong QT • Used for rate control
Sotalol: • Used for rhythm control • Prolongs QT • Higher arrhythmia risk
Compare with:
• Metoprolol (rate control) • Propranolol (nonselective, no QT effect)
Sotalol vs Amiodarone
Amiodarone: • Also Class III • More effective but more toxic
Sotalol: • Cleaner systemic profile • Greater torsades risk
Clinical Pearls
✔ Nonselective beta-blocker + Class III antiarrhythmic ✔ Prolongs QT interval ✔ Risk of torsades de pointes ✔ Requires renal dose adjustment ✔ Used for rhythm control, not simple rate control
Related:
→ Beta-Blockers Overview → Dysrhythmias Module → Return to Cardiovascular Modules
